Advanced Glycation End Products (AGEs) in Diet and Skin in Relation to Stool Microbiota: The Rotterdam Study
Nutrients · 30.05.2023 · 15 (11) · 2567
DOI: 10.3390/nu15112567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 30.05.2023. Verfasst von Jinluan Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Gastrointestinal Microbiome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Erasmus Medical Center, Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw).
Abstract (Originalsprache)
Background
Advanced glycation end products (AGEs) are involved in age-related diseases, but the interaction of gut microbiota with dietary AGEs (dAGEs) and tissue AGEs in the population is unknown.
Objective
Our objective was to investigate the association of dietary and tissue AGEs with gut microbiota in the population-based Rotterdam Study, using skin AGEs as a marker for tissue accumulation and stool microbiota as a surrogate for gut microbiota.
Design
Dietary intake of three AGEs (dAGEs), namely carboxymethyl-lysine (CML), N-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MGH1), and carboxyethyl-lysine (CEL), was quantified at baseline from food frequency questionnaires. Following up after a median of 5.7 years, skin AGEs were measured using skin autofluorescence (SAF), and stool microbiota samples were sequenced (16S rRNA) to measure microbial composition (including alpha-diversity, beta-dissimilarity, and taxonomic abundances) as well as predict microbial metabolic pathways. Associations of both dAGEs and SAF with microbial measures were investigated using multiple linear regression models in 1052 and 718 participants, respectively. Results: dAGEs and SAF were not associated with either the alpha-diversity or beta-dissimilarity of the stool microbiota. After multiple-testing correction, dAGEs were not associated with any of the 188 genera tested, but were nominally inversely associated with the abundance of Barnesiella, Colidextribacter, Oscillospiraceae UCG-005, and Terrisporobacter, in addition to being positively associated with Coprococcus, Dorea, and Blautia. A higher abundance of Lactobacillus was associated with a higher SAF, along with several nominally significantly associated genera. dAGEs and SAF were nominally associated with several microbial pathways, but none were statistically significant after multiple-testing correction.
Conclusions
Our findings did not solidify a link between habitual dAGEs, skin AGEs, and overall stool microbiota composition. Nominally significant associations with several genera and functional pathways suggested a potential interaction between gut microbiota and AGE metabolism, but validation is required. Future studies are warranted, to investigate whether gut microbiota modifies the potential impact of dAGEs on health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
- Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
ORCID-Profile: Trudy Voortman, Robert Kraaij, M Carola Zillikens
Förderung
- Erasmus Medical Center
- Erasmus University
- Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw)
- Research Institute for Diseases in the Elderly (RIDE)
- Netherlands Genomics Initiative
- Ministry of Education, Culture and Science
- Ministry for Health, Welfare and Sports
- European Commission (DG XII)
Zitieren
APA
Chen, J., Radjabzadeh, D., Medina-Gomez, C., Voortman, T., van Meurs, J. B. J., Ikram, M. A., Uitterlinden, A. G., Kraaij, R., & Zillikens, M. C. (2023). Advanced Glycation End Products (AGEs) in Diet and Skin in Relation to Stool Microbiota: The Rotterdam Study. Nutrients, 15(11), 2567. https://doi.org/10.3390/nu15112567
Vancouver
Chen J, Radjabzadeh D, Medina-Gomez C, Voortman T, van Meurs JBJ, Ikram MA, et al. Advanced Glycation End Products (AGEs) in Diet and Skin in Relation to Stool Microbiota: The Rotterdam Study. Nutrients. 2023;15(11):2567. doi:10.3390/nu15112567
BibTeX
@article{Chen2023,
author = {Chen, Jinluan and Radjabzadeh, Djawad and Medina-Gomez, Carolina and Voortman, Trudy and van Meurs, Joyce B J and Ikram, M Arfan and Uitterlinden, André G and Kraaij, Robert and Zillikens, M Carola},
title = {Advanced Glycation End Products (AGEs) in Diet and Skin in Relation to Stool Microbiota: The Rotterdam Study},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {11},
pages = {2567},
doi = {10.3390/nu15112567}
}
EUVIMED